BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2252812)

  • 1. Transient effects of subcutaneously administered prostaglandin E2 on cancellous and cortical bone in young adult dogs.
    Li XJ; Jee WS; Li YL; Patterson-Buckendahl P
    Bone; 1990; 11(5):353-64. PubMed ID: 2252812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats.
    Jee WS; Mori S; Li XJ; Chan S
    Bone; 1990; 11(4):253-66. PubMed ID: 2242291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy.
    Ke HZ; Jee WS; Zeng QQ; Li M; Lin BY
    Bone Miner; 1993 Jun; 21(3):189-201. PubMed ID: 8400919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic effect of prostaglandin E2 on cortical bone of aged male rats comes mainly from modeling-dependent bone gain.
    Yao W; Jee WS; Zhou H; Lu J; Cui L; Setterberg R; Liang T; Ma Y
    Bone; 1999 Dec; 25(6):697-702. PubMed ID: 10593415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prostaglandin E2 and F2 alpha on the skeleton of osteopenic ovariectomized rats.
    Ma YF; Li XJ; Jee WS; McOsker J; Liang XG; Setterberg R; Chow SY
    Bone; 1995 Dec; 17(6):549-54. PubMed ID: 8835309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of prostaglandin E2-induced extra cortical bone after its withdrawal in rats.
    Jee WS; Ke HZ; Li XJ
    Bone Miner; 1992 Apr; 17(1):31-47. PubMed ID: 1581704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of new trabecular bone in osteopenic ovariectomized rats by prostaglandin E2.
    Mori S; Jee WS; Li XJ
    Calcif Tissue Int; 1992 Jan; 50(1):80-7. PubMed ID: 1739875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of orally administered prostaglandin E-2 on cortical bone turnover in adult dogs: a histomorphometric study.
    High WB
    Bone; 1987; 8(6):363-73. PubMed ID: 3482354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous infusion of PGE2 is catabolic with a negative bone balance on both cancellous and cortical bone in rats.
    Tian XY; Zhang Q; Zhao R; Setterberg RB; Zeng QQ; Ma YF; Jee W SS
    J Musculoskelet Neuronal Interact; 2007; 7(4):372-81. PubMed ID: 18094515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term anabolic effects of prostaglandin-E2 on tibial diaphyseal bone in male rats.
    Jee WS; Ke HZ; Li XJ
    Bone Miner; 1991 Oct; 15(1):33-55. PubMed ID: 1747567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anabolic effect of prostaglandin E2 in bone is not dependent on pituitary hormones in rats.
    Chen MM; Yeh JK; Aloia JF
    Calcif Tissue Int; 1998 Sep; 63(3):236-42. PubMed ID: 9701628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 prevents bone loss and adds extra bone to immobilized distal femoral metaphysis in female rats.
    Akamine T; Jee WS; Ke HZ; Li XJ; Lin BY
    Bone; 1992; 13(1):11-22. PubMed ID: 1581103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats.
    Ma YF; Lin BY; Jee WS; Lin CH; Chen YY; Ke HZ; Li XJ
    J Bone Miner Res; 1997 Feb; 12(2):267-75. PubMed ID: 9041060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone.
    Boyce RW; Paddock CL; Franks AF; Jankowsky ML; Eriksen EF
    J Bone Miner Res; 1996 May; 11(5):600-13. PubMed ID: 9157775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancellous bone of aged rats maintains its capacity to respond vigorously to the anabolic effects of prostaglandin E2 by modeling-dependent bone gain.
    Cui L; Ma YF; Yao W; Zhou H; Setterberg RB; Liang TC; Jee WS
    J Bone Miner Metab; 2001; 19(1):29-37. PubMed ID: 11156470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow.
    Weinreb M; Suponitzky I; Keila S
    Bone; 1997 Jun; 20(6):521-6. PubMed ID: 9177865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term daily administration of prostaglandin-E2 on maintaining elevated proximal tibial metaphyseal cancellous bone mass in male rats.
    Ke HZ; Jee WS; Mori S; Li XJ; Kimmel DB
    Calcif Tissue Int; 1992 Mar; 50(3):245-52. PubMed ID: 1617499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous PGE2 leads to net bone loss while intermittent PGE2 leads to net bone gain in lumbar vertebral bodies of adult female rats.
    Tian XY; Zhang Q; Zhao R; Setterberg RB; Zeng QQ; Iturria SJ; Ma YF; Jee WS
    Bone; 2008 May; 42(5):914-20. PubMed ID: 18316259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 prevents disuse-induced cortical bone loss.
    Jee WS; Akamine T; Ke HZ; Li XJ; Tang LY; Zeng QQ
    Bone; 1992; 13(2):153-9. PubMed ID: 1576011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabolic responses of an adult cancellous bone site to prostaglandin E2 in the rat.
    Ito H; Ke HZ; Jee WS; Sakou T
    Bone Miner; 1993 Jun; 21(3):219-36. PubMed ID: 8400921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.